"Lymphangioleiomyomatosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease characterized by the progressive invasion of SMOOTH MUSCLE CELLS into the LYMPHATIC VESSELS, and the BLOOD VESSELS. The majority of the cases occur in the LUNGS of women of child-bearing age, eventually blocking the flow of air, blood, and lymph. The common symptom is shortness of breath (DYSPNEA).
| Descriptor ID |
D018192
|
| MeSH Number(s) |
C04.557.375.460.465 C04.557.450.692.500 C15.604.515.562.465 C20.683.515.710.465
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lymphangioleiomyomatosis".
Below are MeSH descriptors whose meaning is more specific than "Lymphangioleiomyomatosis".
This graph shows the total number of publications written about "Lymphangioleiomyomatosis" by people in this website by year, and whether "Lymphangioleiomyomatosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2017 | 4 | 0 | 4 |
| 2018 | 6 | 2 | 8 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lymphangioleiomyomatosis" by people in Profiles.
-
A 34-Year-Old Woman from Brazil with Pulmonary Lymphangioleiomyomatosis Diagnosed by Raised Serum Vascular Endothelial Growth Factor-D (VEGF-D) Levels and Lung Cysts on Computed Tomography Imaging Presenting with COVID-19 Pneumonia. Am J Case Rep. 2021 Jul 31; 22:e932660.
-
mTORC1 hyperactivation in lymphangioleiomyomatosis leads to ACE2 upregulation in type II pneumocytes: implications for COVID-19. Eur Respir J. 2021 02; 57(2).
-
COVID-19 and lymphangioleiomyomatosis: Experience at a reference center and the potential impact of the use of mTOR inhibitors. Am J Med Genet A. 2020 12; 182(12):3068-3070.
-
Tuberous sclerosis complex (TSC), lymphangioleiomyomatosis, and COVID-19: The experience of a TSC clinic in Italy. Am J Med Genet A. 2020 11; 182(11):2479-2485.
-
Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report. BMC Pulm Med. 2019 Jan 11; 19(1):12.
-
Lymphangioleiomyomatosis (LAM) presenting as recurrent pneumothorax in an infant with tuberous sclerosis: treated successfully with sirolimus. BMJ Case Rep. 2018 Nov 08; 2018.
-
A case of uterine lymphangioleiomyomatosis in a young woman that was identified via peritonitis. J Obstet Gynaecol Res. 2019 Feb; 45(2):482-486.
-
Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis. Curr Opin Pulm Med. 2018 09; 24(5):469-476.
-
The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models. Am J Respir Cell Mol Biol. 2018 06; 58(6):678-683.
-
Immunohistological features related to functional impairment in lymphangioleiomyomatosis. Respir Res. 2018 05 08; 19(1):83.